Efor Group has merged with NODARIUS to enhance its market presence and capabilities in the life sciences consulting sector, aiming to become a global leader by 2028.

Target Information

The Efor Group, a prominent player in the life sciences consulting arena, operates in four countries and projected revenues of €175 million in 2023. Over the past decade, Efor has established itself as one of the leading European firms in its sector, effectively addressing the evolving needs of pharmaceuticals, biotechnology, and medtech industries, while meeting ever-increasing scientific and technical requirements. This achievement positions Efor as a trusted partner for the outsourcing of both operational and strategic activities throughout the product lifecycle.

Driven by dynamism and market recognition, Efor aims to expand its international presence, particularly in Europe and the USA, and plans to invest in the development of its services and expertise, targeting a workforce of 5,000 employees by 2028. The strategy will involve collaboration with local champions in each geography who share a similar core identity and values.

Industry Overview in France

The life sciences consulting industry in France has experienced significant growth, fueled by increasing investments in research and development within pharmaceutical and biotechnology sectors. The country ranks as one of the top markets for healthcare services in Europe